About
Aims
npj Genomic Medicine and Rare Diseases (NPJGMRD) is a premier peer-reviewed, open-access journal dedicated to advancing the clinical application of genomic technologies in the field of rare disease medicine. Our primary aim is to bridge the significant gap between high-throughput sequencing discoveries and tangible patient outcomes. By providing a high-visibility platform for translational research, the journal seeks to accelerate the diagnostic odyssey for individuals with undiagnosed conditions and foster the development of precision therapeutics. We prioritize studies that not only identify novel genetic variants but also provide mechanistic insights or demonstrate the clinical utility of genomic data in diverse healthcare settings.
Scope
The journal welcomes original research, clinical trials, and theoretical frameworks that address the complexities of rare genetic conditions through the following focal areas:
• Integration of whole-genome (WGS) and whole-exome sequencing (WES) into primary and secondary clinical care.
• Development of advanced bioinformatics pipelines and machine learning models for the prioritization of pathogenic variants.
• Functional genomics and cellular modeling techniques for the validation of variants of uncertain significance (VUS).
• Applications of multi-omics approaches, including transcriptomics, proteomics, and metabolomics, to resolve complex phenotypes.
• Pharmacogenomics and the implementation of personalized treatment regimens for orphan diseases.
• Ethical, legal, and social implications (ELSI) of genomic screening, data sharing, and patient privacy in the rare disease community.
• Longitudinal natural history studies and the role of international patient registries in defining rare disease progression.
• Gene editing and novel genetic therapy delivery mechanisms for ultra-rare disorders.
Article Types
To support the dissemination of diverse scientific findings, NPJGMRD accepts the following article formats:
• Original Research Articles
• Clinical Trial Reports
• Brief Communications and Case Series
• Systematic Reviews and Meta-analyses
• Data Descriptors and Resource Papers
• Perspectives and Commentaries on Emerging Policies
• Technical Reports on Diagnostic Pipelines
Audience
The journal is designed to serve a global, multidisciplinary audience including clinical geneticists, molecular pathologists, bioinformaticians, and pharmaceutical researchers. It also provides essential insights for healthcare policy makers, genetic counselors, and patient advocacy groups working to integrate genomic innovation into public health systems and individual patient management.